Cargando…

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma

BACKGROUND: Synaptojanin 2 Binding Protein (SYNJ2BP) is essential to cell proliferation. Previous studies show that SYNJ2BP participates in sprouting angiogenesis, which plays an important part in several abnormal conditions including cancer. However, the activity of SYNJ2BP in hepatocellular carcin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xiao, Zhou, Jiangjiao, Zhou, Ning, Zhu, Jianwei, Feng, Yong, Miao, Xiongying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4955141/ https://www.ncbi.nlm.nih.gov/pubmed/27440153 http://dx.doi.org/10.1186/s13046-016-0385-0

Ejemplares similares

SYNJ2BP promotes the degradation of PTEN through the lysosome-pathway and enhances breast tumor metastasis via PI3K/AKT/SNAI1 signaling
por: Wang, Miao, et al.
Publicado: (2017)

Electroclinical Findings of SYNJ1 Epileptic Encephalopathy
por: Samanta, Debopam, et al.
Publicado: (2020)

The mitochondrial outer membrane protein SYNJ2BP interacts with the cell adhesion molecule TMIGD1 and can recruit it to mitochondria
por: Hartmann, Christian, et al.
Publicado: (2020)

Expression of Synj2bp in mouse liver regulates the extent of wrappER-mitochondria contact to maintain hepatic lipid homeostasis
por: Ilacqua, Nicolò, et al.
Publicado: (2022)

Clinical Variability of SYNJ1-Associated Early-Onset Parkinsonism
por: Lesage, Suzanne, et al.
Publicado: (2021)

Temporal Vestibular Deficits in synaptojanin 1 (synj1) Mutants
por: Gao, Yan, et al.
Publicado: (2021)

Outcome of robot-assisted pancreaticoduodenectomy during initial learning curve versus laparotomy
por: Zhou, Jiangjiao, et al.
Publicado: (2020)

SYNJ1 gene associated with neonatal onset of neurodegenerative disorder and intractable seizure
por: Al Zaabi, Nuha, et al.
Publicado: (2017)

SYNJ2 is a novel and potential biomarker for the prediction and treatment of cancers: from lung squamous cell carcinoma to pan-cancer
por: Hou, Wei, et al.
Publicado: (2022)

Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis
por: Huang, Qing Bo, et al.
Publicado: (2014)

Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations
por: Fasano, Dominga, et al.
Publicado: (2018)

Parkinsonism mutations in DNAJC6 cause lipid defects and neurodegeneration that are rescued by Synj1
por: Jacquemyn, Julie, et al.
Publicado: (2023)

Tryptanthrin inhibits tumor angiogenesis via Notch/Dll4 signaling pathway in zebrafish
por: Lin, Meimei, et al.
Publicado: (2023)

A micropeptide JunBP regulated by TGF-β promotes hepatocellular carcinoma metastasis
por: Zhang, Hongwei, et al.
Publicado: (2022)

Discovery of NKCC1 as a potential therapeutic target to inhibit hepatocellular carcinoma cell growth and metastasis
por: Zhou, Yaya, et al.
Publicado: (2017)

Divergent functions and distinct localization of the Notch ligands DLL1 and DLL3 in vivo
por: Geffers, Insa, et al.
Publicado: (2007)

Context-Dependent Functional Divergence of the Notch Ligands DLL1 and DLL4 In Vivo
por: Preuße, Kristina, et al.
Publicado: (2015)

Endothelial Dll4 overexpression reduces vascular response and inhibits tumor growth and metastasization in vivo
por: Trindade, Alexandre, et al.
Publicado: (2017)

Inhibition of Dll4/Notch1 pathway promotes angiogenesis of Masquelet’s induced membrane in rats
por: Tang, Qian, et al.
Publicado: (2018)

Klf4 inhibits tumor growth and metastasis by targeting microRNA-31 in human hepatocellular carcinoma
por: Tian, Chuan, et al.
Publicado: (2017)

Down Syndrome Fetal Fibroblasts Display Alterations of Endosomal Trafficking Possibly due to SYNJ1 Overexpression
por: De Rosa, Laura, et al.
Publicado: (2022)

A novel SYNJ1 homozygous variant causing developmental and epileptic encephalopathy in an Afro‐Caribbean individual
por: Maj, Mary, et al.
Publicado: (2022)

Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway
por: Liao, Shengtao, et al.
Publicado: (2020)

ENO3 Inhibits Growth and Metastasis of Hepatocellular Carcinoma via Wnt/β-Catenin Signaling Pathway
por: Cui, Honglei, et al.
Publicado: (2021)

KCTD11 inhibits growth and metastasis of hepatocellular carcinoma through activating Hippo signaling
por: Tong, Rongliang, et al.
Publicado: (2017)

SERPINA11 Inhibits Metastasis in Hepatocellular Carcinoma by Suppressing MEK/ERK Signaling Pathway
por: Song, Ye, et al.
Publicado: (2021)

Incomplete Dll4/Notch signaling inhibition promotes functional angiogenesis supporting the growth of skin papillomas
por: Djokovic, Dusan, et al.
Publicado: (2015)

A humanized anti-DLL4 antibody promotes dysfunctional angiogenesis and inhibits breast tumor growth
por: Jia, Xuelian, et al.
Publicado: (2016)

MicroRNA-200a inhibits cell growth and metastasis by targeting Foxa2 in hepatocellular carcinoma
por: Chen, Shu-ying, et al.
Publicado: (2017)

MicroRNA-3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1
por: Zhang, Lijuan, et al.
Publicado: (2019)

Distinct expression patterns of Notch ligands, Dll1 and Dll4, in normal and inflamed mice intestine
por: Shimizu, Hiromichi, et al.
Publicado: (2014)

Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma
por: Wang, Ke, et al.
Publicado: (2022)

Dll4/Notch1 signalling pathway is required in collective invasion of salivary adenoid cystic carcinoma
por: Wang, Ke, et al.
Publicado: (2021)

A 28 nt long synthetic 5(′)UTR (synJ) as an enhancer of transgene expression in dicotyledonous plants
por: Kanoria, Shaveta, et al.
Publicado: (2012)

Organ microenvironment affects growth and metastasis of hepatocellular carcinoma via the TGF-β/Smad pathway in mice
por: LI, GUOCAI, et al.
Publicado: (2013)

ASPP2 inhibits tumor growth by repressing the mevalonate pathway in hepatocellular carcinoma
por: Liang, Beibei, et al.
Publicado: (2019)

SLFN11 inhibits hepatocellular carcinoma tumorigenesis and metastasis by targeting RPS4X via mTOR pathway
por: Zhou, Chenhao, et al.
Publicado: (2020)

Vascular endothelial growth factor 165 inhibits pro-fibrotic differentiation of stromal cells via the DLL4/Notch4/smad7 pathway
por: Lv, Haining, et al.
Publicado: (2019)

Harnessing DLL3 inhibition: From old promises to new therapeutic horizons
por: Cortinovis, Diego Luigi, et al.
Publicado: (2022)

Targeting the DLL/Notch Signaling Pathway in Cancer: Challenges and Advances in Clinical Development
por: You, Weon-Kyoo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4tkh6ahk2b4klg96kohhjktg5u